HEAD & NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD & NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD & NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis study tests whether adding the targeted drug nimotuzumab to standard radiation therapy helps people with advanced head and neck cancer live longer without the cancer growing or spreading. It is for patients who cannot receive platinum-based chemotherapy. About 335 adults wil…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Apr 29, 2026 08:47 UTC
-
New hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis phase 3 trial tests a new treatment for high-risk head and neck cancer patients who cannot receive the standard chemotherapy drug cisplatin. After surgery, patients get radiation therapy combined with nimotuzumab (a targeted drug) followed by benmelstobart (an immunotherapy)…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Apr 29, 2026 08:45 UTC